Hideaki Ijichi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Blocking L-carnitine synthesis by meldonium prolongs the survival in mice with pancreatic cancer.
Journal: iScience
Published: October 03, 2025
High-Dose Tramadol Enhances the Proliferative and Invasive Potential of Pancreatic Ductal Adenocarcinoma in Mice Through Microenvironmental Alteration.
Journal: Pain research & management
Published: August 02, 2025
Predicting the risk of developing diabetes in steatotic liver disease using controlled attenuation parameter in a health checkup population.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: April 22, 2025
Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 18, 2025
Blockade of CC chemokine receptor 2 suppresses pancreatic cancer progression through the interaction with macrophages in the tumor microenvironment.
Journal: Scientific reports
Published: December 21, 2024
Development of a novel PIK3CA-mutated pancreatic tumor mouse model and evaluation of the therapeutic effects of a PI3K inhibitor.
Journal: PloS one
Published: November 07, 2024
WWP1 inhibition suppresses the proliferation of pancreatic cancer cells by regulating the PI3K-AKT pathway.
Journal: Journal of gastroenterology
Published: September 12, 2024
Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer.
Journal: BMC pharmacology & toxicology
Published: July 18, 2024
Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
Journal: The New England journal of medicine
Published: May 29, 2024
Last Updated: 09/26/2026